Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_assertion type Assertion NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_head.
- NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_assertion description "[We used INS 832/13 cells, rat islets isolated from wild-type or human islet amyloid polypeptide (h-IAPP) transgenic rats, and pancreatic tissue from rats and humans with and without type 2 diabetes and investigated the effect of CDK5/p35 inhibition (by small interfering RNA or by chemical inhibition) as well as CDK5/p35 overexpression on ?-cell vulnerability to apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_provenance.
- NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_assertion evidence source_evidence_literature NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_provenance.
- NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_assertion SIO_000772 21378178 NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_provenance.
- NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_assertion wasDerivedFrom befree-20140225 NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_provenance.
- NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_assertion wasGeneratedBy ECO_0000203 NP783320.RAGGx1qxvD4p5BvnCqwM457MLztVg_MEb_C-ThYLfrHKI130_provenance.